- Regeneron Pharmaceuticals Inc (NASDAQ:REGN) plans to spend $1.8 billion and hire 1,000 new workers as part of an ambitious, two-phase expansion at its Tarrytown, NY campus.
- The investment will expand its research, preclinical manufacturing, and support facilities.
- The blueprints include space for eight new buildings, three parking garages, and a massive 900,000-square-foot central utility plant on site.
- In all, the project will take six years to complete and could bring $283 million in direct and indirect revenue for the NY state government and add $2 billion to the state’s economy.
- It’s a rosy deal from Cuomo, reportedly Regeneron CEO Len Schleifer’s close associate, who signed off on the $100 million in hiring incentives that will come with the deal.
- The governor has had a close relationship with Regeneron since his father signed a $250,000 check from the state’s Empire State Development Corporation to invest in the drugmaker in 1989, just a year into its existence.
- Price Action: REGN shares are down 0.72% at $584.08 during the market session on the last check Friday.
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.
